Novo Nordisk Shares Fall After Q2 Earnings Despite Raised Annual Outlook
Novo Nordisk A/S (NYSE:NVO) reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis). Operating profit…
AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations
AmerisourceBergen Corp’s (NYSE:ABC) Q3 FY22 adjusted EPS reached $2.62, up 21.3% Y/Y, beating the consensus of $2.57. Revenue of $60.1…
Regeneron’s Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned $9.77 per share for Q2 FY22, down 62% Y/Y, beating the $9.54 estimate. Sales decreased…
Horizon Therapeutics’ Shares Tumble On Q2 Miss, Trimmed FY22 Outlook
Horizon Therapeutics plc’s (NASDAQ:HZNP) reported Q2 sales of $876.4 million, +5% Y/Y, missing the consensus of $936.10 million. The adjusted…
Merck’s Two Keytruda Combo Cancer Trials Miss Primary Goal
Merck & Co Inc’s (NYSE:MRK) Phase 3 KEYNOTE-921 trial of Keytruda combined with chemotherapy (docetaxel) did not meet its dual…
CVS Health Q2 Sales Up Across Insurance & Pharmacy, Lifts Annual Outlook
CVS Health Corp’s (NYSE:CVS) Q2 sales increased 11% Y/Y to $80.6 billion, beating the consensus of $76.37 billion. Prescriptions filled…
IDEXX Laboratories Misses on Q2 Earnings, Issues FY22 Guidance Below Consensus
IDEXX Laboratories Inc (NASDAQ:IDXX) reported Q2 revenues of $861 million, an increase of 4% Y/Y on a reported basis and…
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
Zimmer Biomet Holdings Inc’s (NYSE:ZBH) Q2 sales increased by 1% Y/Y to $1.78 billion (up 6% on a constant currency basis),…
DuPont Revises Annual Guidance, Trails Wall Street Estimates, Shares Tick Lower
DuPont de Nemours Inc (NYSE: DD) Q2 sales increased 7% Y/Y to $3.3 billion, missing the consensus of $4.2 billion.
Why Uber Shares Are Rising
Shares of Uber Technologies Inc. (NYSE: UBER) are trading higher following a strong earnings report from the ride-share company.